U.S. Preventive Services 
Task Force banner
U.S. Preventive Services Task Force

You Are Here: U.S. Preventive Services Task Force > Topic Index > Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia

This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on low-dose aspirin for the prevention of morbidity and mortality from preeclampsia (formerly aspirin prophylaxis in pregnancy).

Current Recommendation

Release Date: 1996

Guide to Clinical Preventive Services, 2nd Edition
Aspirin Prophylaxis in Pregnancy

Update in Progress

In an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of many of its documents for public comment, including draft Research Plans and draft Recommendation Statements. As a result, the final Recommendation Statement is not yet available.

Supporting Documents

Evidence Review

The research team at the Evidence-based Practice Center independently gathers and reviews the available published evidence to address the questions posed by the USPSTF. The resulting draft Evidence Review is critiqued by national subject matter experts before being finalized.

Evidence Review Related Items
Evidence Summary (PDF File, 355 KB; PDF Help) Final Evidence Review (PDF File, 1.4 MB; PDF Help)

Recommendation Statement

The USPSTF reviews the final Evidence Review, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more preliminary specific recommendations. The resulting draft Recommendation Statement is posted on this Web site for public comment before being finalized.

Recommendation Statement Related Items
Draft Recommendation Statement for Public Comment*
(April 8–May 5, 2014)
Consumer Fact Sheet (PDF File, 69 KB; PDF Help)

* Note: Draft Recommendation Statements are by their nature not final, and should not be interpreted as to represent official USPSTF recommendations for practice. Draft Recommendation Statements are provided by the USPSTF for informational purposes only.

Current as of May 2014

Internet Citation:

Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsaspg.htm


USPSTF Program Office  540 Gaither Road, Rockville, MD 20850